|
ImmunoGen
|
7.6 |
$42M |
|
1.4M |
29.65 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
6.3 |
$35M |
|
3.3M |
10.44 |
|
Cerevel Therapeutics Hldng I
(CERE)
|
5.8 |
$32M |
|
750k |
42.40 |
|
Cymabay Therapeutics
|
4.7 |
$26M |
|
1.1M |
23.62 |
|
Madrigal Pharmaceuticals
(MDGL)
|
4.2 |
$23M |
|
100k |
231.38 |
|
Xenon Pharmaceuticals
(XENE)
|
3.9 |
$21M |
|
460k |
46.06 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
3.8 |
$21M |
|
17M |
1.21 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
3.5 |
$19M |
|
541k |
35.58 |
|
Arcellx Common Stock
(ACLX)
|
3.4 |
$19M |
|
340k |
55.50 |
|
Lianbio Sponsored Ads
(LIANY)
|
3.1 |
$17M |
|
3.8M |
4.47 |
|
Celldex Therapeutics Com New
(CLDX)
|
2.9 |
$16M |
|
400k |
39.66 |
|
Apogee Therapeutics
(APGE)
|
2.7 |
$15M |
|
537k |
27.94 |
|
Immunovant
(IMVT)
|
2.7 |
$15M |
|
345k |
42.13 |
|
Cytokinetics Com New
(CYTK)
|
2.4 |
$13M |
|
160k |
83.49 |
|
Nuvalent Inc-a
(NUVL)
|
2.4 |
$13M |
|
175k |
73.59 |
|
Establishment Labs Holdings Ord
(ESTA)
|
2.1 |
$12M |
|
453k |
25.89 |
|
Astria Therapeutics
(ATXS)
|
2.1 |
$11M |
|
1.5M |
7.68 |
|
Verona Pharma Sponsored Ads
(VRNA)
|
2.0 |
$11M |
|
564k |
19.88 |
|
Spyre Therapeutics Com New
(SYRE)
|
2.0 |
$11M |
|
518k |
21.52 |
|
Alkermes SHS
(ALKS)
|
1.9 |
$11M |
|
383k |
27.74 |
|
Autolus Therapeutics Spon Ads
(AUTL)
|
1.8 |
$10M |
|
1.6M |
6.44 |
|
Eyepoint Pharmaceuticals Com New Put Option
(EYPT)
|
1.8 |
$9.9M |
|
430k |
23.11 |
|
Inozyme Pharma
(INZY)
|
1.5 |
$8.0M |
|
1.9M |
4.26 |
|
Nurix Therapeutics
(NRIX)
|
1.3 |
$7.1M |
|
690k |
10.32 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
1.2 |
$6.3M |
|
796k |
7.96 |
|
Apellis Pharmaceuticals
(APLS)
|
1.1 |
$6.0M |
|
100k |
59.86 |
|
Mirati Therapeutics
|
1.1 |
$5.9M |
|
100k |
58.75 |
|
Alnylam Pharmaceuticals Call Option
(ALNY)
|
1.0 |
$5.7M |
|
30k |
191.41 |
|
Roivant Sciences SHS
(ROIV)
|
1.0 |
$5.6M |
|
500k |
11.23 |
|
Viking Therapeutics
(VKTX)
|
1.0 |
$5.6M |
|
300k |
18.61 |
|
Savara
(SVRA)
|
1.0 |
$5.4M |
|
1.2M |
4.70 |
|
Compass Pathways Sponsored Ads
(CMPS)
|
0.9 |
$4.8M |
|
550k |
8.75 |
|
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
0.8 |
$4.3M |
|
71k |
60.39 |
|
Dynavax Technologies Corp Com New
(DVAX)
|
0.8 |
$4.2M |
|
300k |
13.98 |
|
Structure Therapeutics Sponsored Ads Call Option
(GPCR)
|
0.7 |
$4.1M |
|
100k |
40.76 |
|
Astrazeneca Sponsored Adr
(AZN)
|
0.7 |
$4.0M |
|
60k |
67.35 |
|
Axsome Therapeutics
(AXSM)
|
0.7 |
$4.0M |
|
50k |
79.59 |
|
Springworks Therapeutics
(SWTX)
|
0.7 |
$3.7M |
|
100k |
36.50 |
|
Omeros Corp Note 5.250% 2/1 (Principal)
|
0.7 |
$3.6M |
|
6.0M |
0.60 |
|
Coherus Biosciences Note 1.500% 4/1 (Principal)
|
0.6 |
$3.4M |
|
6.0M |
0.57 |
|
Relay Therapeutics
(RLAY)
|
0.6 |
$3.3M |
|
300k |
11.01 |
|
Bridgebio Pharma
(BBIO)
|
0.6 |
$3.2M |
|
80k |
40.37 |
|
Krystal Biotech
(KRYS)
|
0.6 |
$3.1M |
|
25k |
124.06 |
|
Cullinan Oncology
(CGEM)
|
0.6 |
$3.1M |
|
300k |
10.19 |
|
Tango Therapeutics
(TNGX)
|
0.5 |
$3.0M |
|
300k |
9.90 |
|
Argenx Se Sponsored Adr
(ARGX)
|
0.5 |
$2.9M |
|
7.5k |
380.43 |
|
Kura Oncology
(KURA)
|
0.5 |
$2.8M |
|
192k |
14.38 |
|
Cassava Sciences Call Option
(SAVA)
|
0.5 |
$2.7M |
|
121k |
22.51 |
|
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
0.5 |
$2.5M |
|
20k |
125.95 |
|
Mersana Therapeutics
|
0.4 |
$2.3M |
|
1.0M |
2.32 |
|
Immatics SHS
(IMTX)
|
0.4 |
$2.1M |
|
200k |
10.53 |
|
Penumbra
(PEN)
|
0.3 |
$1.9M |
|
7.5k |
251.54 |
|
Tourmaline Bio
(TRML)
|
0.3 |
$1.8M |
|
68k |
26.18 |
|
Adc Therapeutics Sa SHS
(ADCT)
|
0.3 |
$1.7M |
|
1.0M |
1.66 |
|
Vaxcyte
(PCVX)
|
0.3 |
$1.6M |
|
25k |
62.80 |
|
Kalvista Pharmaceuticals
(KALV)
|
0.3 |
$1.5M |
|
126k |
12.25 |
|
Mirum Pharmaceuticals
(MIRM)
|
0.3 |
$1.5M |
|
50k |
29.52 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.3 |
$1.4M |
|
125k |
11.17 |
|
Neurocrine Biosciences
(NBIX)
|
0.2 |
$1.3M |
|
10k |
131.76 |
|
Inari Medical Ord
|
0.2 |
$1.3M |
|
20k |
64.92 |
|
Allogene Therapeutics
(ALLO)
|
0.2 |
$1.3M |
|
400k |
3.21 |
|
Morphic Hldg
(MORF)
|
0.2 |
$1.2M |
|
43k |
28.88 |
|
Miragen Therapeutics
(VRDN)
|
0.2 |
$1.1M |
|
50k |
21.78 |
|
Biohaven
(BHVN)
|
0.2 |
$893k |
|
21k |
42.80 |
|
Puma Biotechnology
(PBYI)
|
0.2 |
$876k |
|
202k |
4.33 |
|
Fulcrum Therapeutics
(FULC)
|
0.2 |
$844k |
|
125k |
6.75 |
|
Avrobio Ord
(AVRO)
|
0.1 |
$680k |
|
500k |
1.36 |
|
Immatics W Exp 07/01/202
(IMTXW)
|
0.1 |
$547k |
|
187k |
2.92 |
|
Newamsterdam Pharma Company W Exp 11/22/202
(NAMSW)
|
0.1 |
$429k |
|
137k |
3.13 |
|
Terns Pharmaceuticals
(TERN)
|
0.1 |
$428k |
|
66k |
6.49 |
|
Nuvation Bio Com Cl A
(NUVB)
|
0.1 |
$378k |
|
250k |
1.51 |
|
Context Therapeutics
(CNTX)
|
0.1 |
$372k |
|
329k |
1.13 |
|
Inflarx Nv
(IFRX)
|
0.1 |
$326k |
|
200k |
1.63 |
|
Promis Neurosciences Com New
(PMN)
|
0.1 |
$306k |
|
266k |
1.15 |
|
Aravive
|
0.0 |
$43k |
|
347k |
0.12 |
|
Rocket Pharmaceuticals W Exp 09/02/202
(RCKTW)
|
0.0 |
$37k |
|
75k |
0.49 |